諾輝健康-B(06606.HK)與基金及NHH Ventures訂立認購協議
格隆匯8月20日丨諾輝健康-B(06606.HK)發佈公吿,2021年8月20日,公司一間全資附屬公司NHH Ventures Holding Limited與基金及NHH Ventures訂立認購協議,據此,公司同意認購基金的有限合夥權益,資本承擔為3000萬美元,及根據有限合夥協議的條款及條件成為基金的有限合夥人。
同日,NHH Ventures(以其普通合夥人身份)、Dr. Ethan Hu(以其基金最初有限合夥人身份)及NHH Ventures(作為基金每個有限合夥人不時的實際授權人及代理)訂立有限合夥協議,以規管合夥人之間的關係,並規範基金的管理。由於NHH Ventures Holding Limited已成為基金的有限合夥人,因此將須遵守有限合夥協議的條款。基金主要專注於投資用於癌症及其他重大疾病類別領域疾病篩查及早期檢測的分子診斷技術領域。
公吿表示,公司為一家生物科技公司,主要從事開發及商業化創新癌症篩查產品。公司經常尋求於該領域的投資機會。投資於基金符合該業務策略,乃公司一項有價值的投資。此外,透過投資於基金,公司將能夠利用基金的基金經理及其他合獲人的專長及資源物色潛在的市場投資目標。董事相信該策略性發展將對公司投資創新癌症篩查行業的策略佈局形成補充。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.